AI-generated analysis. Always verify with the original filing.
Moleculin Biotech, Inc. filed an 8-K on 2026-02-20 disclosing Item 1.01 incorporating a material definitive agreement by reference and Item 3.02 for the issuance of Inducement Warrants as an unregistered sale of equity securities exempt from registration requirements. Exhibit 4.1 is a Form of Inducement Warrant.
Event Type
Disclosure
Mandatory
Variant
8-K
of this Form 8-K is incorporated by reference herein. Item 9.01. Financial Statements and Exhibits. (d) Exhibits No. Description 4.1 Form of Inducement Warrant
Unregistered Sales of Equity Securities The Company issued the Inducement Warrants pursuant to the exemption from the registration requirements of the Securitie